Early research (Phase 1)Study completedNCT06263270
What this trial is testing
Evaluation of CYT-108, A Recombinant Protease Inhibitor, for Treatment of Mild To Moderate Primary Osteoarthritis Of The Knee
Who this might be right for
Osteoarthritis, KneeOsteoarthritis
Cytonics Corporation 19